Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Stanford Federal Credit Union Now Live with Prizeout
-
Boston Scientific (BSX) Appoints Jessica L. Mega and Susan E. Morano to its Board
-
Enovix (ENVX) Announces Appointment of Joseph Malchow and Bernard Gutmann to Its Board of Directors
-
Acrivon Therapeutics (ACRV) Appoints Charles Baum to its Board
-
Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories (Intonation) form a collaboration to fight cancerous neuroendocrine tumors
-
ABVC BioPharma, Inc (ABVC) Projects $1M Proceeds From Dietary Supplement Production
-
Timber Pharmaceuticals (TMBR) to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
-
Stanford Pathology Chair and Expert in Alzheimer's and Parkinson's Disease Joins Enable Medicine's Scientific Advisory Board to Advance Digital Pathology Capabilities
-
Stitch Fix (SFIX) Appoints Matt Baer as CEO, Katrina Lake to Continue as Executive Chairperson of the Board
-
Stanford Medicine and Stanford Institute for Human-Centered Artificial Intelligence announce RAISE-Health, a responsible AI initiative
-
Beyond Meat (BYND) Debuts the Newest Iteration of Beyond Sausage, the #1 Selling Plant-Based Sausage, at Over 15,000 Retail Outlets Nationwide
-
Immix Biopharma's (IMMX) Nexcella Appoints Henry McKinnell, Jr to its Board
-
Roku (ROKU) Appoints Jeff Blackburn to its Board
-
Keysight World: Innovate to Explore Rapidly Evolving Technologies Reshaping the Human Experience
-
Private Sector Adds 278 Thousand Jobs in May
-
TG Therapeutics (TGTX) Announces Data from ULTIMATE I & II Phase 3 Trials of BRIUMVI in Multiple Sclerosis to be Presented at CMSC
-
Noodles & Company (NDLS) Announces Thomas Lynch Appointed to Board of Directors
-
Pinterest (PINS) announces Julia Brau Donnelly to join as Chief Financial Officer
-
AERWINS Technologies (AWIN) Appoints Katie Field and Pavan Gill to its Board
-
Lazard Ltd. (LAZ) Appoints Peter R. Orszag as CEO, Kenneth M. Jacobs as Chairman
-
Politan Calls on Shareholders to Elect Independent Oversight Masimo Corp's (MASI) Board
-
ABVC BioPharma's (ABVC) Vitargus Phase II Study Received Ethical Approval at Sydney Eye Hospital in Australia
-
Krystal Biotech (KRYS) Receives FDA Approval for VYJUVEK
-
Form 4 Syneos Health, Inc. For: May 16 Filed by: Rudnick Stanford
-
Sarcos Technology (STRC) Appoints Laura Peterson as Interim President and CEO
-
President Biden Announces Nominees to the Federal Reserve Board of Governors
-
Stanford Medicine Named Winner of the 2023 Hearst Health Prize in Partnership with the UCLA Center for SMART Health
-
Stanford Medicine Children's Health Receives Rare Disease Centers of Excellence Designation
-
Abeona Therapeutics (ABEO) Announces Additional Phase 3 VIITAL Study Results for EB-101
-
Jasper Therapeutics (JSPR) Appoints Stephen J. Galli to its Board
-
Beyond Steak (BYND) Is Now Certified by the American Heart Association’s Heart-Check Program
-
GE HealthCare (GEHC) Names James Saccaro Vice President and Chief Financial Officer
-
Knight-Hennessy Scholars announces 2023 cohort of new scholars, its largest ever
-
Tivic Health Systems (TIVC) Launches B2B Portal
-
Marker Therapeutics (MRKR) Appoints Monic Stuart as Chief Medical Officer
-
Sight Sciences (SGHT) Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis
-
Stanford Spinoff PhysioWave Announces Clinical Study with Omron Healthcare
-
ABVC BioPharma, Inc (ABVC) Receives US Patent Certificate of PDC-1421
-
Predictive Oncology (POAI) Appoints Veena Rao to its Board
-
Syneos Health (SYNH) Appoints Michael Bonello as CFO
-
Syneos Health Appoints Michael Bonello as Chief Financial Officer
-
Biora Therapeutics (BIOR) Appoints Ariella Kelman as Chief Medical Officer
-
Xencor (XNCR) Appoints Nancy Valente as Chief Development Officer
-
Trustmark Corporation Announces First Quarter 2023 Financial Results
-
Form 4 Syneos Health, Inc. For: Apr 18 Filed by: Rudnick Stanford
-
Beyond Air, Inc. (XAIR) Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy
-
Form 3 Trio Petroleum Corp. For: Apr 17 Filed by: Eschner Stanford
-
Ocean Biomedical (OCEA) Announces $134M in Financial Backing, Provides Latest Updates
-
Procter & Gamble (PG) Appoints Sheila Bonini and Rob Portman to its Board
-
eFFECTOR Therapeutics (EFTR) to Collaborate with Stanford Medicine on Investigator-Initiated Randomized Phase 2 Study in Patients with ER+ Breast Cancer

